Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
M
MPRS
vs
T
Tel Aviv 355
Over the past 12 months, MPRS has underperformed Tel Aviv 355, delivering a return of -14% compared to Tel Aviv 355's +26% growth.
Stocks Performance
MPRS vs Tel Aviv 355
Performance Gap
MPRS vs Tel Aviv 355
Performance By Year
MPRS vs Tel Aviv 355
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Medipress Health LP
Glance View
Medipress Health-LP engages in research and development. Company's aim is to invest in medical research and development (R&D) startup companies that are exclusively specialized in digital and advanced breaking through technologies. Its investees are active in the field of medical and digital medicine, including digital artificial intelligence (AI) solutions and in the field of remote diagnostic care. Company's portfolio includes Cure and Gynamics. The Cure is engaged in developing proton therapy for cancer treatment. Gynamincs is engaged in developing non-surgical vaginal solutions for women with various Pelvic Floor Disorders. Medipress Health LP primarily invests in startups from Israel.